MigraineMind research summary
The Combined Effect of Migraine and Smoking on Premature Stroke and All-Cause Mortality in Parous Women: A Population-Based Cohort Study.
Neurology | 2026
Observational studySummary
This study looked at how migraine and smoking together affect women's health. Researchers focused on women who had given birth in Denmark between 1996 and 2022. They tracked these women to see if they experienced premature strokes or died from any cause. The study included over 1.6 million women, with a median age of 29 to 32 years. Results showed that women with both migraine and smoking had higher risks. Specifically, the 20-year risk of premature ischemic stroke was 0.8% for women without either condition. Those with migraines had a 1.4% risk, and smokers had a 2.0% risk. Women with both conditions faced an even greater risk. The findings suggest that migraine and smoking together significantly increase the likelihood of serious health issues. This research highlights the importance of addressing both factors in women's health management. Clinical relevance: This study indicates that managing migraine and smoking could reduce stroke risk in women.
Key Learning Points
- Women who experience migraines and smoke have a significantly increased risk of serious health issues.
- The combination of migraines and smoking raises the risk of premature strokes in women.
- Addressing both migraines and smoking is crucial for improving women's health outcomes.
- The study tracked over 1.6 million women, emphasizing the scale of the health risks involved.
- Managing these two factors could help reduce stroke risk among affected women.
Research Informatics
REGISTRY STUDY
Migraine and smoking linked to higher stroke and mortality risk.
conditionMigraine and smoking
sample Size1677707
populationParous women aged 15-60 in Denmark
study DesignRetrospective cohort
exposureMigraine and smoking
comparatorWomen with neither migraine nor smoking
Original research
Read the original publication and review its full methods and findings on PubMed.
MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.
